The Serum Institute of India (SII) will join a growing CEPI network of vaccine producers in the Global South.
It aims to support more rapid, agile, and equitable responses to future disease outbreaks.
Coalition for Epidemic Preparedness Innovations (CEPI) is an innovative global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats.
CEPI has articulated an aspirational goal: vaccines should be ready for initial authorisation and manufacturing at scale within 100 days of recognition of a pandemic pathogen, when appropriate.
This alliance will be a significant boost to vaccine production efforts in Global South regions, and take it a step closer to achieving the 100 Days Mission.